Welcome to our dedicated page for Sofi Technologies SEC filings (Ticker: SOFI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Problem: SoFi’s disclosures cover everything from FDIC-insured deposits to Galileo platform APIs—hundreds of pages that can overwhelm even seasoned analysts. If you have ever typed “SoFi SEC filings explained simply� or hunted for the latest “SoFi quarterly earnings report 10-Q filing,� you know the challenge.
Solution: Stock Titan’s AI reads every SoFi annual report 10-K, 8-K, 10-Q and proxy in seconds, then surfaces what matters: loan performance, bank capital ratios, technology-platform margins and customer-growth milestones. Our platform answers the exact questions investors ask—“understanding SoFi SEC documents with AI,â€� “SoFi insider trading Form 4 transactions,â€� or “SoFi proxy statement executive compensation.â€� AGÕæÈ˹ٷ½-time alerts flag “SoFi Form 4 insider transactions real-time,â€� while concise cards turn dense text into actionable insights so you can benchmark member growth without sifting through footnotes.
Why it matters: Whether you need a quick “SoFi earnings report filing analysis,� details on “SoFi executive stock transactions Form 4,� or context for “SoFi 8-K material events explained,� our coverage is exhaustive. Receive AI-powered summaries, downloadable exhibits and historical trend charts the moment each filing hits EDGAR. Save hours, spot opportunities and make decisions based on the complete story hidden inside every SoFi document.
Supernus has completed its cash/CVR acquisition of Sage Therapeutics (SAGE). The tender offer, priced at $8.50 per share in cash plus one contingent value right (CVR) worth up to an additional $3.50, expired at one minute past 11:59 p.m. ET on 30 Jul 2025 and was not extended. Equiniti Trust Company, acting as depositary, reported that 36,313,509 shares—approximately 58 % of Sage’s outstanding common stock—were validly tendered and not withdrawn, satisfying the offer’s minimum condition. All tendered shares were irrevocably accepted for payment and will be settled promptly in accordance with the Merger Agreement.
On 31 Jul 2025, immediately after the offer closing, Purchaser was merged into Sage under DGCL §251(h), making Sage a wholly owned subsidiary of Supernus. As a consequence, Sage’s common stock will be delisted from the Nasdaq Global Market and deregistered under the Exchange Act.
- Tender consideration: $8.50 cash + CVR (up to $3.50).
- Shares tendered: 36.3 M (�58 % of total outstanding).
- Offer expiration: 30 Jul 2025; merger completion: 31 Jul 2025.
All other disclosures in the original Schedule 14D-9 remain unchanged.
On 29 Jul 2025, Larimar Therapeutics (LRMR) furnished a Form 8-K (Item 2.02) to disclose preliminary liquidity for the quarter ended 30 Jun 2025. Management estimates $138.5 million in cash, cash equivalents and marketable securities at that date.
The amount is unaudited and subject to change pending completion of the Q2 closing and review process. No additional operating results, balance-sheet details, or forward guidance were included. The same figure appears in a preliminary prospectus supplement filed under Rule 424(b)(5). Because the data are “furnished� rather than “filed,� they are not subject to Exchange Act Section 18 liability.
AZZ Inc. (AZZ) Form 4 filing: Chief Operating Officer of Metal Coatings, Bryan L. Stovall, sold 5,000 AZZ common shares on 07/16/2025 at a weighted-average price of $107.979 (price band $107.75-$108.185). After the sale, Stovall retains 27,709 shares held directly.
The transaction, valued at roughly $540k, represents an estimated 15% reduction in his personal position. No derivative securities were involved. The report was filed five days late due to broker notification delays, as noted in the remarks section.
No other material events, option exercises, or additional insider transactions are disclosed in this filing.
SoFi Technologies (SOFI) EVP Kelli Keough reported a significant insider transaction on June 20, 2025, selling 10,267 shares at a weighted average price of $15.2224 per share (ranging from $15.02 to $15.57). The total transaction value amounts to approximately $156,300.
Key details of the transaction:
- The sale was executed according to a pre-established Rule 10b5-1 Trading Plan adopted on May 21, 2024
- Following the transaction, Keough retains direct ownership of 255,467 shares
- The transaction was completed in multiple trades within the specified price range
This insider sale by a senior executive provides important information for investors monitoring insider trading patterns at SoFi Technologies. The structured nature of the sale through a 10b5-1 plan suggests this was a planned transaction rather than a reactive market decision.
SoFi Technologies (SOFI) Chief Technology Officer Jeremy Rishel has reported a significant insider transaction on June 20, 2025. The executive sold 66,847 shares at a price of $15.55 per share, resulting in a transaction value of approximately $1.04 million.
Following the transaction, Rishel continues to hold 724,321 shares directly. The sale was executed according to a Rule 10b5-1 Trading Plan established on May 23, 2024, which provides a pre-scheduled trading framework to help avoid accusations of insider trading.
Key transaction details:
- Transaction Type: Sale of Common Stock
- Ownership Type: Direct Ownership
- Trading Plan: Executed under Rule 10b5-1
- Filing Status: Form 4 filed within required timeframe
SoFi Technologies, Inc. (SOFI) filed a Form 144 indicating that Kelli Keough intends to sell 31,112 common shares through J.P. Morgan Securities on or about 20 June 2025. The filing lists an aggregate market value of $477,880, implying a transaction price based on recent market quotations. The shares represent an immaterial fraction of the company’s 1,105,363,096 shares outstanding.
The document also discloses Keough’s prior sales over the last three months: 11,181 shares on 21 Apr 2025, 11,520 shares on 20 May 2025, and 59,962 shares on 17 Jun 2025, generating combined gross proceeds of $1,152,744. The current sale arises from the vesting of restricted stock units on 14 Jun 2025 and is classified as compensation.
No comments were provided in the remarks section, and there is no indication of a Rule 10b5-1 trading plan adoption date. By signing the notice, the filer asserts the absence of undisclosed material adverse information, as required under Rule 144.
SoFi Technologies, Inc. (SOFI) � Form 144 insider sale notice. The filing discloses that Jeremy D. Rishel has notified the SEC of an intention to sell 66,847 common shares on or about 20 June 2025. The shares were acquired through restricted-stock vesting on 14 June 2025 and will be routed through Fidelity Brokerage Services LLC for execution on the NASDAQ.
The planned sale represents an estimated market value of $1.04 million based on the filing’s reference price, and equals roughly 0.006% of SoFi’s 1.11 billion shares outstanding, indicating an immaterial dilution impact. However, it follows prior insider sales by the same individual over the last three months:
- 68,625 shares on 20 Mar 2025 for $867,420
- 140,494 shares on 17 Jun 2025 for $2,059,333
No adverse, non-public information is claimed by the filer, and the disclosure appears routine under Rule 144. Nonetheless, the consecutive insider sales could be interpreted by some investors as a negative sentiment signal, albeit the absolute quantities are small relative to float.
Derek J. White, CEO of Galileo at SoFi Technologies (SOFI), reported significant insider transactions on June 16-17, 2025:
- Acquired 152,759 shares through RSU settlements: - 148,404 shares from previous grants (2021-2024) - 4,355 shares from March 2025 grant
- Disposed of 64,467 shares at $14.658 per share to satisfy tax withholding obligations
- Following these transactions, White directly owns 1,049,383 shares
- Maintains additional unvested RSUs: - 509,227 units from 2021-2024 grants - 256,997 units from 2025 grant
These transactions reflect scheduled RSU vesting events and associated tax-related share sales, rather than discretionary trading activity. The substantial holdings indicate significant alignment with shareholder interests.